NISCAIR Online Periodicals Repository

Research Journals >
Indian Journal of Biochemistry and Biophysics (IJBB) >
IJBB Vol.43 [2006] >
IJBB Vol.43(1) [February 2006] >

Title: Antibodies against 9-O-acetylated sialic acids in childhood acute lymphoblastic leukemia: A two-year study with 186 samples following protocol MCP 943
Authors: Bandyopadhyay, Suman
Chatterjee, Mitali
Banavali, Shripad D
Pal, Santanu
Nair, Chandrika N
Advani, Suresh H
Mandal, Chitra
Keywords: Acute lymphoblastic leukemia
9-O-acetylated sialoglycoconjugates (9-OAcSGs)
Bovine submaxillary mucin
Issue Date: Feb-2006
Publisher: CSIR
Abstract: Initial studies have revealed an enhanced surface expression of 9-O-acetylated sialoglycoconjugates (9-OAcSGs) on lymphoblasts concomitant with high titers of antibodies (anti-9-OAcSGs) in childhood acute lymphoblastic leukemia (ALL) ¹⁻⁴. This study was undertaken in 186 coded samples from 69 ALL patients to evaluate if antibodies against these sialoglycans could monitor response to the treatment. An ELISA was developed using bovine submaxillary mucin (BSM) containing high % of 9-O-acetylated sialic acids (9-OAcSA) as the capture antigen, to investigate serum levels of anti 9-OAcSGs in a single-center series of pediatric, clinically-diagnosed and immunophenotypically confirmed ALL patients, as compared to 130 healthy controls. At presentation, a 3.8-fold increase in anti-9-OAcSGs levels was detected in 63/69 ALL patients (mean ± SEM was 102.8 ± 6.3 g/ml) as compared to normal controls (27.17 ± 0.76 g/ml), assay sensitivity being 91.3%. On an individual basis (n = 25) in patients who were longitudinally monitored for two years, a significant decline in their mean ± SEM of OD405 was observed from 0.85 ± 0.06 to 0.28 ± 0.03. Additionally, a dot-blot was developed to evaluate the proportion of immune-complexed 9-OAcSGs in these patients employing achatinin-H, a 9-OAcSA-binding lectin. Our data indicate that these economically viable ELISA-based approaches allow for reliable, sensitive and rapid diagnosis of ALL. We contend that these disease-specific antibodies could be considered as potential markers both for the initial diagnosis of ALL and possibly for longitudinal monitoring of the disease.
Page(s): 7-14
ISSN: 0301-1208
Source:IJBB Vol.43(1) [February 2006]

Files in This Item:

File Description SizeFormat
IJBB 43(1) 7-14.pdf132.18 kBAdobe PDFView/Open
 Current Page Visits: 115 
Recommend this item


Online Submission of Articles |  NISCAIR Website |  National Knowledge Resources Consortium |  Contact us |  Feedback

Disclaimer: NISCAIR assumes no responsibility for the statements and opinions advanced by contributors. The editorial staff in its work of examining papers received for publication is helped, in an honorary capacity, by many distinguished engineers and scientists.

CC License Except where otherwise noted, the Articles on this site are licensed under Creative Commons License: CC Attribution-Noncommercial-No Derivative Works 2.5 India

Copyright © 2015 The Council of Scientific and Industrial Research, New Delhi. All rights reserved.

Powered by DSpace Copyright © 2002-2007 MIT and Hewlett-Packard | Compliant to OAI-PMH V 2.0

Home Page Total Visits: 167102 since 01-Sep-2015  Last updated on 28-Jun-2016Webmaster: